COMMUNICATION
Interaction of Drosophila Inhibitors of Apoptosis with Thick Veins, a Type I Serine/Threonine Kinase Receptor for Decapentaplegic*

Eiichi OedaDagger §, Yoshitomo Oka§, Kohei MiyazonoDagger , and Masahiro KawabataDagger par

From the Dagger  Department of Biochemistry, The Cancer Institute, Tokyo, Japanese Foundation for Cancer Research and Research for the Future Program, Japan Society for the Promotion of Science, 1-37-1 Kami-Ikebukuro, Toshima-ku, Tokyo 170-8455, Japan and the § Third Department of Internal Medicine, Yamaguchi University School of Medicine, 1144 Kogushi, Ube, Yamaguchi 755-8505,Japan

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Decapentaplegic (Dpp) is a Drosophila member of bone morphogenetic proteins, which belong to the transforming growth factor-beta superfamily. Members of this family regulate a variety of biological processes such as cell proliferation, morphogenesis, immune response, and apoptosis. Dpp plays a critical role in many aspects of Drosophila development. Members of the transforming growth factor-beta superfamily bind to two different types of serine/threonine kinase receptors, termed type I and type II. Type I receptors act as downstream components of type II receptors in the receptor complexes. Therefore, intracellular proteins that interact with the type I receptors are likely to play important roles in signaling. Several proteins have been identified through protein-protein interaction screenings. We identified Drosophila inhibitor of apoptosis (DIAP) 1 as an interacting protein of a Dpp type I receptor, Thick veins (Tkv). DIAP1 associates with Tkv in vivo. The binding region in DIAP1 is mapped to its C-terminal RING finger region. DIAP2, another Drosophila member of the inhibitor of apoptosis protein family, also interacts with Tkv in vivo. These data suggest that DIAP1 and DIAP2 may be involved, possibly as negative regulators, in the Dpp signaling pathway, which leads to cell apoptosis.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Transforming growth factor-beta s (TGF-beta s),1 bone morphogenetic proteins (BMPs), and activins belong to a large family of cytokines that regulate a variety of biological processes such as cell proliferation, morphogenesis, immune response, and apoptosis (1, 2). Ligands of this superfamily have been identified in organisms from invertebrates to vertebrates. In Drosophila, three factors, Decapentaplegic (Dpp), 60A, and Screw, have been isolated, and all of them belong to the BMP subfamily (3, 4). Dpp plays an important role during Drosophila development. Dpp acts as a morphogen to establish the patterning of the dorsal ectoderm. Dpp also regulates gut morphogenesis and growth of imaginal discs such as wings and eyes.

Dpp has been an ideal molecule for studying the signaling mechanism of the TGF-beta superfamily, because a wide range of genetic approaches are applicable in Drosophila. Mothers against dpp (Mad) was identified as a genetic enhancer of the dpp phenotypes (5). Maternally, Mad mutations exacerbated the embryonal leathality caused by dpp mutations. Mad mutations also enhanced various dpp phenotypes associated with appendages such as wings, eyes, and claws in zygotes. Sma proteins in Caenorhabditis elegans are structurally similar to Mad (6). An increasing number of vertebrate homologs of Mad and Sma have been identified and are now generically denoted Smad. Eight different Smads (Smad1-Smad8) have been identified in mammals, and they are biochemically demonstrated to mediate signals of the TGF-beta superfamily proteins (2, 4, 7).

Signals of TGF-beta are transduced into the cell by two types of serine/threonine kinase receptors (1, 2). The type II TGF-beta receptor (Tbeta R-II) is a constitutively active kinase. Upon ligand binding, Tbeta R-II recruits and phosphorylates the type I TGF-beta receptor (Tbeta R-I). Phosphorylation of Tbeta R-I occurs mainly at the GS domain, a glycine-serine-rich region highly conserved among the type I receptors. Mutation of threonine 204 in the GS domain to aspartic acid resulted in constitutive activation of Tbeta R-I (8). This demonstrates that Tbeta R-I is the effector kinase that phosphorylates cytoplasmic substrates, now revealed as Smad2 and Smad3 (2). Upon phosphorylation by Tbeta R-I, Smad2 and Smad3 form a complex with Smad4 and translocate into the nucleus where they activate transcription of the target genes.

Yeast two-hybrid screenings using the cytoplasmic region of Tbeta R-I or Tbeta R-II as a bait have led to the identification of various proteins such as FKBP12 (9-13), farnesyl-protein transferase-alpha (14-16), TRIP-1 (17), and apolipoprotein J (18). Although farnesyl transferase-alpha is phosphorylated both in vitro and in vivo by Tbeta R-I, little is known about its role in TGF-beta signaling. FKBP12 binds to the juxtamembrane region of Tbeta R-I. FKBP12 has been shown to prevent spontaneous activation of Tbeta R-I by Tbeta R-II (13). TRIP-1 and apolipoprotein J interact with Tbeta R-II, but their functions in signal transduction of TGF-beta remain to be determined.

We employed the two-hybrid system to identify proteins that interact with the cytoplasmic region of Thick veins (Tkv), one of the type I receptors for Dpp (4). One positive clone encoded Drosophila inhibitor of apoptosis 1 (DIAP1), which is structurally similar to baculovirus inhibitor of apoptosis protein (IAP) (19). Moreover, we show that Tkv interacts with DIAP1 in vivo. DIAP2, another Drosophila member of the IAP family (19), also interacts with Tkv.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Plasmid Construction-- The bait plasmid, pEG-Tkv, encoding the fusion protein of the LexA DNA-binding domain and the cytoplasmic region of Tkv was constructed as follows. The cytoplasmic region of Tkv was amplified by polymerase chain reaction (PCR) from the full-length clone, Brk25D2 (20), and inserted between the EcoRI and XhoI sites of pEG202 (21). The prey plasmid of Tkv, pJG-Tkv, was constructed by inserting the EcoRI-XhoI fragment into pJG4-5 (21). Tkv mutants were constructed by site-directed mutagenesis using the Chameleon mutagenesis kit (Stratagene). Tkv (Delta JM) lacks the juxtamembrane region (amino acids 205-254) of the wild type Tkv. Tkv (Q253D) and Tkv (K281R) have aspartic acid instead of glutamine 253 and arginine instead of lysine 281, respectively. pcDNA3-HA was made by inserting an annealed oligonucleotide between the XhoI and XbaI sites of pcDNA3 (Invitrogen). pcDNA3-FLAG was described (11). The whole coding region of Tkv was amplified by PCR with an EcoRI and an XhoI site added before the starting codon and in place of the stop codon, respectively, followed by insertion between the EcoRI and XhoI sites of pcDNA3-HA. The internal EcoRI site of Tkv was removed by site-directed mutagenesis. The yeast expression plasmids of DIAP1 were made by subcloning the EcoRI-XhoI fragment amplified by PCR into pEG202 and pJG4-5. The coding region of DIAP1 without the stop codon was subcloned between the EcoRI and XhoI sites of pcDNA3-FLAG, yielding FLAG-tagged DIAP1. The DIAP2 plasmids were constructed in a similar manner to DIAP1. The details of the plasmid construction including the oligonucleotide sequences are available upon request. All of the PCR products were sequenced.

Screening and Interaction Assay-- A Drosophila imaginal disc cDNA expression library (gift of R. Brent) was screened using the interaction trap (21) exactly as described (14). Briefly, the yeast strain, EGY48, was transformed with the reporter, pSH18-34 (21), and pEG-Tkv. The cDNA library was then introduced into EGY48. The transformants were grown on appropriate selection medium, and positive clones were selected depending on beta -galactosidase activity and leucine prototrophy. Library plasmids were rescued from EGY48, amplified in bacteria, and sequenced. Interaction assays using the interaction trap were done as described before (14).

Cloning of the Full-length DIAP1-- One of the positive clones contained a partial C-terminal region of DIAP1 (see Fig. 1A). PCR was performed under a standard condition to amplify the missing N-terminal region from a Drosophila 4-8-h-old embryo cDNA library in the pNB40 vector (gift of Y. Nishida). The full coding region of DIAP1 was made by ligating the EcoRI-BanII fragment obtained from PCR and the BanII-XhoI fragment obtained from the interaction trap screen.

Protein Interaction in Vivo-- COS-7 cells were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, 100 units/ml penicillin, and 4.5 g/liter glucose. Cells were transiently transfected using DMRIE-C (Life Technologies, Inc.) with 10 µg of plasmids. After 2 days, cells were labeled with 22.8 mCi/ml [35S]methionine and cysteine mixture (Amersham Pharmacia Biotech) for 5 h and lysed in 150 mM NaCl, 20 mM Tris-HCl, pH 7.5, and 1% Triton X-100 containing 1.5% of aprotinin. Cleared lysates were divided into two tubes and incubated with anti-FLAG M2 (Eastman Kodak) or anti-HA 12CA5 (Boehringer Mannheim) monoclonal antibodies. Immune complexes were bound to protein G-Sepharose (Amersham Pharmacia Biotech) or protein A-Sepharose (Amersham Pharmacia Biotech). The precipitates were washed and subjected to SDS-polyacrylamide gel electrophoresis (PAGE) (8.5% or 10% gel) and analyzed with Fuji BAS 2000 Bio-Imaging Analyzer (Fuji Photo Film).

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

To search for proteins that interact with Tkv, we employed the interaction trap screen developed by Brent and co-workers (21). A Drosophila imaginal disc cDNA library was screened with the cytoplasmic region of Tkv as a bait. 160,000 transformants were screened. Finally, four positive clones were isolated. One clone encoded Drosophila FKBP12, a homolog of human FKBP12 that is known as a binding protein for mammalian type I receptors, including Tbeta R-I (9, 11, 13) (data not shown). One of the other clones, termed PC1, encoded a partial C-terminal region of DIAP1 (Fig. 1A), which is a homolog of baculovirus IAP (19). The remaining two positive clones were not analyzed. PCR using a Drosophila 4-8-h-old embryo cDNA library was performed to obtain the missing N-terminal region.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 1.   Interaction of DIAPs with Dpp receptors in yeast. A, shown is the schematic representation of DIAPs and the truncated forms of DIAP1 used in the following experiments. Numbers indicate amino acid positions. PC1 is the original DIAP1 clone obtained from the interaction trap screen. B, various combinations of a bait (receptors) and a prey (DIAPs) with a reporter plasmid were introduced into EGY48. Three independent colonies from each transformation were streaked onto an indicator plate to assay the beta -galactosidase activities. Strength of interaction was evaluated by the relative intensity of blue color among colonies. The mutants of Tkv are described in the text. C, interaction of the truncated forms of DIAP1 with Dpp receptors. ND, not done.

We then examined the interaction of the full-length DIAP1 with Tkv using the interaction trap (Fig. 1B). DIAP1 strongly interacted with the wild type Tkv, although its interaction was slightly weaker than that of the partial clone, PC1. Mutants of Tkv with different signaling activities were also tested for the interaction with DIAP1. One Tkv mutant replacing glutamine 253 with aspartic acid (QD), reported to have a constitutively kinase activity (22), showed strong interaction with DIAP1 as well as with PC1. Another mutant replacing lysine 281 with arginine (KR), which is expected to lack the kinase activity (8), showed weak interaction with DIAP1 and PC1. We also tested a deletion mutant lacking the juxtamembrane region (amino acids 205-254) where probable transphosphorylation sites by the type II receptor exist (8). The mutant, Tkv (Delta JM), did not interact with PC1 or DIAP1. Contrary to Tkv, Saxophone (Sax), another Dpp type I receptor (20, 23-25) or Punt, a type II receptor for Dpp (26-28), did not interact with PC1 or DIAP1. Thus, DIAP1 specifically interacted with Tkv in the yeast system.

In Drosophila, two types of IAP are known (19). DIAP2, another Drosophila inhibitor of apoptosis, has three baculovirus IAP repeat (BIR) domains, whereas DIAP1 has two BIR domains (Fig. 1A). We tested whether DIAP2 interacts with Tkv. DIAP2 did not show interaction with the wild type or mutants of Tkv, Sax, or Punt in the yeast system (Fig. 1B). To identify the interacting region of DIAP1 with Tkv, we constructed various truncated forms (TF) of DIAP1 (Fig. 1A). The wild type Tkv showed interaction with TF4 that has only the RING finger domain but not with the other truncated forms (Fig. 1C). Thus, the interacting region in DIAP1 is mapped to the RING finger domain. Sax and Punt did not interact with TF4.

We next examined the interaction between DIAP1 and Tkv in vivo. DIAP1 was epitope-tagged with FLAG at the C terminus (DIAP1-FLAG). HA-tagged Tkv and/or DIAP1-FLAG were transiently expressed in COS-7 cells. Labeled lysates were immunoprecipitated with anti-HA or anti-FLAG monoclonal antibodies and then subjected to SDS-PAGE (Fig. 2A). Each antibody specifically recognized Tkv-HA and DIAP1-FLAG, respectively (Fig. 2A, fourth and seventh lanes from the left). Anti-FLAG antibody coprecipitated Tkv only when DIAP1 was expressed, demonstrating that DIAP1 interacts with Tkv in vivo (Fig. 2A, ninth lane from the left). Both constitutively active (QD) and kinase-inactive (KR) mutants interacted with DIAP1 as efficiently as the wild type Tkv (Fig. 2A, eleventh and thirteenth lanes from the left). The reason for the difference between this result in COS-7 cells and that in the yeast assay (Fig. 1B) is not known, but the difference in mammalian cells and in yeast was also observed in the interaction of FKBP12 with Tbeta R-I (11).


View larger version (76K):
[in this window]
[in a new window]
 
Fig. 2.   Association of DIAPs with Tkv in vivo. A, COS-7 cells were transfected with the plasmids indicated and labeled with [35S]methionine/cysteine mixture, and the lysates were immunoprecipitated with anti-HA (H) or anti-FLAG (F) antibodies. The precipitates were subjected to SDS-PAGE (8.5% gel) and phosphoimaging analysis. The bracket indicates the position of DIAP1. Faster migrating bands are thought to be degradates and/or partial translation products of DIAP1. The arrow indicates Tkv. The numbers on the left represent molecular masses of markers (in kDa). Various forms of Tkv are used: wt, the wild type; QD, constitutively active form; and KR, kinase-negative form. B, COS-7 cells were transfected with FLAG-tagged DIAP2 in combination with the wild type or mutant Tkv plasmids. Interaction was detected as in Fig. 2. The arrows indicate the positions of Tkv and DIAP2.

We also tested the interaction of DIAP2 with Tkv in vivo. Tkv-HA and/or DIAP2-FLAG were transiently transfected in COS-7 cells (Fig. 2B). Although the interaction of DIAP2 with Tkv was not detected in the yeast assay (Fig. 1B), DIAP2 coprecipitated not only with the wild type Tkv but also with the QD and KR mutants in vivo.

To determine the region of DIAP1 required for the interaction with Tkv in vivo, expression plasmids of the BIR domain (BIR-FLAG) and C-terminal region of DIAP1 (PC1-FLAG) were constructed (Fig. 3A). Tkv-HA was coexpressed with BIR-FLAG or PC1-FLAG (Fig. 3B). Tkv-HA was detected in a stable complex only with PC1-FLAG but not with BIR-FLAG (Fig. 3B, eleventh and thirteenth lanes from the left). These results indicate that the interaction region of DIAP1 is the C terminus, which contains the RING finger domain, consistent with the results in the yeast assay. TF4-FLAG that has only the RING finger domain was tested, but the expression level was too low to detect interaction (data not shown).


View larger version (59K):
[in this window]
[in a new window]
 
Fig. 3.   Region of DIAP1 responsible for interaction with Tkv in vivo. A, shown is the schematic representation of the DIAP1 constructs used in the experiment. B, COS-7 cells were transfected with the wild type Tkv in combination with the BIR domain or RING finger domain of DIAP1. The arrows indicate the positions of Tkv and various forms of DIAP1.

    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Members of the TGF-beta superfamily regulate growth, differentiation, and apoptosis of various cell types. Recent data have clearly shown that Smad proteins transduce signals for the TGF-beta superfamily proteins; however, it is likely that other signaling pathways may exist for the TGF-beta superfamily. BMPs and TGF-beta have been reported to induce apoptosis both in vitro and in vivo (29, 30). More recently, caspase family proteases, such as interleukin-1beta converting enzyme (ICE), are involved in the apoptosis signals for the TGF-beta superfamily (30). However, it is not yet known whether Smads are involved in the apoptosis pathway.

DIAP1 is a homolog of the baculovirus IAP that prevents cell apoptosis when virus infects cells. Recently, an increasing number of IAPs have been reported in virus (OpIAP, CpIAP) (31, 32), Drosophila (DIAP1, DIAP2/DIAP/DIHA/dILP) (33-35), mouse (MIHA, mc-IAP-1) (34, 36), and human (XIAP/hILP, MIHB/c-IAP1/hIAP2, MIHC/c-IAP2/hIAP1, neuronal apoptosis inhibitory protein) (33-35). IAPs share conserved regions, i.e. two or three BIR domains at the N-terminal region and one RING finger domain at the C-terminal region, with an exception of neuronal apoptosis inhibitory protein that has three BIR domains but not the RING finger domain. It has been reported that IAPs are able to prevent cell apoptosis induced by ICE (34, 35, 37), although direct interaction of IAPs with ICE has not been shown.

Because IAPs prevent apoptosis of the cells, proteins that interact with IAPs seem to play important roles for cell death signals. Tumor necrosis factor receptor-associated factor 1 and 2 (36), and tumor necrosis factor receptor-1-associated death domain protein, a 34-kDa cytoplasmic protein containing a C-terminal death domain (38) were shown to associate with mammalian IAPs. Drosophila Doom, which induces apoptosis in insect cells, interacts with viral IAPs (39). Reaper is a small polypeptide with 65 amino acids that induces apoptosis in Drosophila. DIAP2 prevents Reaper-induced cell death by binding to it (40). All of the five proteins above bind to IAPs through the BIR domains, whereas Tkv associates with DIAP1 through the RING finger domain.

Mutations of DIAP1 enhanced apoptosis caused by Reaper, whereas overexpression of DIAPs in Drosophila eyes suppressed normally occurring cell death, causing rough eye phenotype (19). Tkv QD mutant induces rough eye (22), suggesting a possible involvement of Tkv in the apoptosis signal pathway. Our results suggest that Tkv may induce apoptosis by suppressing the DIAP1 function. Future studies will be directed to investigate how the interaction between Tkv and DIAP1 is regulated, which molecules are targets of Tkv-DIAP1 pathway, and whether Smad proteins are linked to the signaling activity of DIAP1.

    ACKNOWLEDGEMENTS

We thank R. Brent for reagents of the interaction trap and the cDNA library, M. Hoffmann for Tkv and Sax cDNAs, K. Basler for Punt cDNA, Y. Nishida for a Drosophila cDNA library, G. Rubin for DIAP2 cDNA, and Y. Inada for excellent technical assistance.

    FOOTNOTES

* This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science and Culture of Japan and special coordination funds for promoting science and technology from the Science and Technology Agency.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Supported by the Toray Scientific Foundation and Uehara Memorial Foundation.

par To whom correspondence should be addressed. Tel.: 81-3-5394-3866; Fax: 81-3-3918-0342; E-mail: mkawabat-ind{at}umin.u-tokyo.ac.jp.

1 The abbreviations used are: TGF, transforming growth factor; BMP, bone morphogenetic protein; Tbeta R, TGF-beta receptor; IAP, inhibitor of apoptosis; DIAP, Drosophila IAP; BIR, baculovirus IAP repeat; ICE, interleukin-1beta converting enzyme; PCR, polymerase chain reaction; PAGE, polyacrylamide gel electrophoresis; HA, hemagglutinin.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Kingsley, D. M. (1994) Genes Dev. 8, 133-146[CrossRef][Medline] [Order article via Infotrieve]
  2. Heldin, C.-H., Miyazono, K., and ten Dijke, P. (1997) Nature 390, 465-471[CrossRef][Medline] [Order article via Infotrieve]
  3. Hogan, B. L. M. (1996) Genes Dev. 10, 1580-1594[CrossRef][Medline] [Order article via Infotrieve]
  4. Padgett, R. W., Savage, C., and Das, P. (1997) Cytokine Growth Factor Rev. 8, 1-9[CrossRef][Medline] [Order article via Infotrieve]
  5. Sekelsky, J. J., Newfeld, S. J., Raftery, L. A., Chartoff, E. H., and Gelbart, W. M. (1995) Genetics 139, 1347-1358[Abstract/Free Full Text]
  6. Savage, C., Das, P., Finelli, A. L., Townsend, S. R., Sun, C. Y., Baird, S. E., and Padgett, R. W. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 790-794[Abstract/Free Full Text]
  7. Chen, Y., Bhushan, A., and Vale, W. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 12938-12943[Abstract/Free Full Text]
  8. Wieser, R., Wrana, J. L., and Massagué, J. (1995) EMBO J. 14, 2199-2208[Abstract]
  9. Wang, T., Donahoe, P. K., and Zervos, A. S. (1994) Science 265, 674-676[Medline] [Order article via Infotrieve]
  10. Wang, T., Li, B. Y., Danielson, P. D., Shah, P. C., Rockwell, S., Lechleider, R. J., Martin, J., Manganaro, T., and Donahoe, P. K. (1996) Cell 86, 435-444[Medline] [Order article via Infotrieve]
  11. Okadome, T., Oeda, E., Saitoh, M., Ichijo, H., Moses, H. L., Miyazono, K., and Kawabata, M. (1996) J. Biol. Chem. 271, 21687-21690[Abstract/Free Full Text]
  12. Charng, M. J., Kinnunen, P., Hawker, J., Brand, T., and Schneider, M. D. (1996) J. Biol. Chem. 271, 22941-22944[Abstract/Free Full Text]
  13. Chen, Y. G., Liu, F., and Massagué, J. (1997) EMBO J. 16, 3866-3876[Abstract/Free Full Text]
  14. Kawabata, M., Imamura, T., Miyazono, K., Engel, M. E., and Moses, H. L. (1995) J. Biol. Chem. 270, 29628-29631[Abstract/Free Full Text]
  15. Wang, T., Danielson, P. D., Li, B. Y., Shah, P. C., Kim, S. D., and Donahoe, P. K. (1996) Science 271, 1120-1122[Abstract]
  16. Ventura, F., Liu, F., Doody, J., and Massagué, J. (1996) J. Biol. Chem. 271, 13931-13934[Abstract/Free Full Text]
  17. Chen, R. H., Miettinen, P. J., Maruoka, E. M., Choy, L., and Derynck, R. (1995) Nature 377, 548-552[CrossRef][Medline] [Order article via Infotrieve]
  18. Reddy, K. B., Karode, M. C., Harmony, A. K., and Howe, P. H. (1996) Biochemistry 35, 309-314[CrossRef][Medline] [Order article via Infotrieve]
  19. Hay, B. A., Wassarman, D. A., and Rubin, G. M. (1995) Cell 83, 1253-1262[Medline] [Order article via Infotrieve]
  20. Penton, A., Chen, Y., Staehling, H. K., Wrana, J. L., Attisano, L., Szidonya, J., Cassill, J. A., Massagué, J., and Hoffmann, F. M. (1994) Cell 78, 239-250[Medline] [Order article via Infotrieve]
  21. Gyuris, J., Golemis, E., Chertkov, H., and Brent, R. (1993) Cell 75, 791-803[Medline] [Order article via Infotrieve]
  22. Wiersdorff, V., Lecuit, T., Cohen, S. M., and Mlodzik, M. (1996) Development 122, 2153-2162[Abstract/Free Full Text]
  23. Nellen, D., Affolter, M., and Basler, K. (1994) Cell 78, 225-237[Medline] [Order article via Infotrieve]
  24. Brummel, T. J., Twombly, V., Marques, G., Wrana, J. L., Newfeld, S. J., Attisano, L., Massagué, J., O'Connor, M. B., and Gelbart, W. M. (1994) Cell 78, 251-261[Medline] [Order article via Infotrieve]
  25. Xie, T., Finelli, A. L., and Padgett, R. W. (1994) Science 263, 1756-1759[Medline] [Order article via Infotrieve]
  26. Childs, S. R., Wrana, J. L., Arora, K., Attisano, L., O'Connor, M. B., and Massagué, J. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 9475-9479[Abstract]
  27. Ruberte, E., Marty, T., Nellen, D., Affolter, M., and Basler, K. (1995) Cell 80, 889-897[Medline] [Order article via Infotrieve]
  28. Letsou, A., Arora, K., Wrana, J. L., Simin, K., Twombly, V., Jamal, J., Staehling, H. K., Hoffmann, F. M., Gelbart, W. M., Massagué, J., and O'Connor, M. B. (1995) Cell 80, 899-908[Medline] [Order article via Infotrieve]
  29. Zou, H., and Niswander, L. (1996) Science 272, 738-741[Abstract]
  30. Chen, R. H., and Chang, T. Y. (1997) Cell Growth Differ. 8, 821-827[Abstract]
  31. Crook, N. E., Clem, R. J., and Miller, L. K. (1993) J. Virol. 67, 2168-2174[Abstract]
  32. Birnbaum, M. J., Clem, R. J., and Miller, L. K. (1994) J. Virol. 68, 2521-2528[Abstract]
  33. Liston, P., Roy, N., Tamai, K., Lefebvre, C., Baird, S., Cherton, H. G., Farahani, R., McLean, M., Ikeda, J. E., MacKenzie, A., and Korneluk, R. G. (1996) Nature 379, 349-353[CrossRef][Medline] [Order article via Infotrieve]
  34. Uren, A. G., Pakusch, M., Hawkins, C. J., Puls, K. L., and Vaux, D. L. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 4974-4978[Abstract/Free Full Text]
  35. Duckett, C. S., Nava, V. E., Gedrich, R. W., Clem, R. J., Van, D. J., Gilfillan, M. C., Shiels, H., Hardwick, J. M., and Thompson, C. B. (1996) EMBO J. 15, 2685-2694[Abstract]
  36. Rothe, M., Pan, M. G., Henzel, W. J., Ayres, T. M., and Goeddel, D. V. (1995) Cell 83, 1243-1252[Medline] [Order article via Infotrieve]
  37. Hawkins, C. J., Uren, A. G., Hacker, G., Medcalf, R. L., and Vaux, D. L. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 13786-13790[Abstract/Free Full Text]
  38. Shu, H. B., Takeuchi, M., and Goeddel, D. V. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 13973-13978[Abstract/Free Full Text]
  39. Harvey, A. J., Bidwai, A. P., and Miller, L. K. (1997) Mol. Cell. Biol. 17, 2835-2843[Abstract]
  40. Vucic, D., Kaiser, W. J., Harvey, A. J., and Miller, L. K. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 10183-10188[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.